Our current studies and a brief description of each are listed below. More information about these studies, including eligibility criteria, funding sources, and team members involved can be found by clicking the study’s name.
Depression Studies
Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression (H- 54099)
Nmra-335140-301 (koastal-1) A Phase 3, Randomized, Double-blind, Placebo-controlled Study To Evaluate The Effects Of Oral Nmra-335140 Versus Placebo In Participants With Major Depressive Disorder (H-54668)
A Brief Automated Neurocognitive Training To Enhance The Real World Impact Of Ketamine's Rapid Antidepressant Effect (H-55150)
Treatment Resistant Depression Subcallosal Cingulate Network DBS (H-55510)
Post Traumatic Stress Disorder Studies
Imaging AMPA Receptors in PTSD: A Pilot Positron Emission Tomography Study (H - 49839)
Generalized Anxiety Disorder Studies
ENX102-003 for Treatment of Generalized Anxiety Disorder (H- 53469)
